162 related articles for article (PubMed ID: 24586085)
1. Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions.
Reyngold M; Niland J; ter Veer A; Milne D; Bekaii-Saab T; Cohen SJ; Lai L; Schrag D; Skibber JM; Small W; Weiser M; Wilkinson N; Goodman KA
J Natl Compr Canc Netw; 2014 Feb; 12(2):235-43. PubMed ID: 24586085
[TBL] [Abstract][Full Text] [Related]
2. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
3. Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.
Khrizman P; Niland JC; ter Veer A; Milne D; Bullard Dunn K; Carson WE; Engstrom PF; Shibata S; Skibber JM; Weiser MR; Schrag D; Benson AB
J Clin Oncol; 2013 Jan; 31(1):30-8. PubMed ID: 23169502
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.
Kole AJ; Stahl JM; Park HS; Khan SA; Johung KL
J Natl Compr Canc Netw; 2017 Mar; 15(3):355-362. PubMed ID: 28275036
[No Abstract] [Full Text] [Related]
5. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.
Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR
Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509
[TBL] [Abstract][Full Text] [Related]
6. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
[TBL] [Abstract][Full Text] [Related]
7. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients.
Zhao F; Wang J; Yu H; Cheng X; Li X; Zhu X; Xu X; Lin J; Chen X; Yan S
Radiat Oncol; 2020 Feb; 15(1):49. PubMed ID: 32103755
[TBL] [Abstract][Full Text] [Related]
10. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
11. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
12. Influence of neoadjuvant radiotherapy on anastomotic leak after restorative resection for rectal cancer.
Nisar PJ; Lavery IC; Kiran RP
J Gastrointest Surg; 2012 Sep; 16(9):1750-7. PubMed ID: 22744637
[TBL] [Abstract][Full Text] [Related]
13. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
[TBL] [Abstract][Full Text] [Related]
14. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada.
Eldin NS; Yasui Y; Scarfe A; Winget M
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
16. Short-course Versus Long-course Neoadjuvant Therapy for Non-metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database.
Dutta SW; Alonso CE; Jones TC; Waddle MR; Janowski EM; Trifiletti DM
Clin Colorectal Cancer; 2018 Dec; 17(4):297-306. PubMed ID: 30146228
[TBL] [Abstract][Full Text] [Related]
17. The outcome and the frequency of pathological complete response after neoadjuvant radiotherapy in curative resections for advanced rectal cancer: a population-based study.
Wasmuth HH; Rekstad LC; Tranø G
Colorectal Dis; 2016 Jan; 18(1):67-72. PubMed ID: 26201935
[TBL] [Abstract][Full Text] [Related]
18. Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.
Patel SV; Roxburgh CS; Vakiani E; Shia J; Smith JJ; Temple LK; Paty P; Garcia-Aguilar J; Nash G; Guillem J; Wu A; Reyngold M; Weiser MR
J Surg Oncol; 2016 Oct; 114(5):637-641. PubMed ID: 27641934
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
Wu B; Qiu HZ; Xiao Y; Lin GL; Niu BZ; Zhang FQ; Hu K
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):124-7. PubMed ID: 18344077
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Radiotherapy: A Risk Factor for Short-Term Wound Complications after Radical Resection for Rectal Cancer?
Holubar SD; Brickman RK; Greaves SW; Ivatury SJ
J Am Coll Surg; 2016 Aug; 223(2):291-8. PubMed ID: 27112126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
